India Glycols launches wholly-owned subsidiary Ennature Bio Pharma for plant-based ingredients

India Glycols Limited launched Ennature Bio Pharma as its wholly-owned subsidiary to produce nutraceuticals, phytochemicals, and natural plant-based active pharmaceutical ingredients. The subsidiary will offer a wide range of products, including health and wellness supplements. The entity is now named Ennature Bio Pharma Limited, formerly Ennature Bio Pharma Private Limited.

Key facts

Market context

Phytochemicals are plant-derived compounds such as alkaloids, flavonoids, and terpenoids. They are extracted or synthesized for use in nutraceuticals, dietary supplements, cosmetics, and as starting materials or actives in pharmaceuticals. Demand is driven mainly by the growing consumer interest in preventive health and wellness products, along with pharmaceutical companies seeking natural or plant-based active pharmaceutical ingredients. Supply in this segment is fragmented, with many small and mid-sized extractors competing on purity, batch consistency, and regulatory documentation such as good manufacturing practice compliance. Entry by a diversified chemicals group can add capacity and raise competition for buyers sourcing standardized botanical extracts, while potentially pressuring margins for smaller specialty producers. Buyers typically qualify new suppliers through quality audits and certificates of analysis before committing volume.

Source: official release on indiaglycols.com. Summary and context written by Market Krystal.